INTRODUCTION
Vitamin D is a steroid hormone which is required to regulate serum levels of calcium and phosphorus , as well as bone metabolism . Vitamin D can be obtained from dietary sources ( D2 and D3 ) , together with exposure of the skin to ultraviolet ( UV ) light ( D3 ) . The etiologies of hypo-vitaminosis D occurring in end-stage renal disease ( ESRD ) population are not only due to decreased renal ability to transform 1-alpha -hydroxyvitamin D to its active form , but also they include limited sunlight exposure , reduced ultravioletinduced vitamin D synthesis in the skin , and disturbed vitamin D metabolism (4) . Replacement of active vitamin D has been considered an essential step in the management of secondary hyperparathyroidism and its associated disorders in chronic kidney disease (5) . Most patients on dialysis are treated with vitamin D receptor agonists ( VDRAs ) , such as calcitriol , doxercalciferol , or paricalcitol , for management of secondary hyperparathyroidism . Supplementation with VDRAs without its nutritional vitamin D precursor may not optimize clinical benefits (6) . Kovesdy et al.
(7)
,have reported increasing confusion as regards which type of vitamin D preparations ( nutritional versus active formulas ) , should be used within chronic kidney disease patients.
PATIENTS AND METHODS
This is a clinical trial which was carried out on 30 chronic kidney disease stage 3 patients , who attended the Benha Hospital for Health Insurance and the Benha University Hospital outpatient clinics , from April to August 2016 .All patients were above 18 years old . Patients were divided into two groups : Group I: consisted of 19 patients who always had normal blood glucose levels ( Non -diabetic group I).
1942
-Group II: consisted of 11 patients who had abnormal blood glucose levels ( Diabetic group II ).
We excluded from our study pregnant and breastfeeding women , patients who have previously performed parathyroidectomy operation , patients having liver cirrhosis , patients having phenytoin , phenobarbital , or primidone drug usage concurrently to study performance , and lastly patients suffering from either sarcoidosis or malignancies. All particpants to the study were subjected to complete physical examination . For all patients the following parameters were performed : Complete blood count (CBC ) , ESR for first hour (ESR1) and ESR for second hour ( ESR2) , blood urea ( in mg / dl) ,serum creatinine ( in mg / dl ) , estimated glomerular filtration rate ( e GFR in ml / min /1.73 m 2 ) , complete urine analysis , protein / creatinine ratio ( in mg / mmol ) , serum sodium ( Na in m Eq / L )and other electrolytes as required , serum calcium ( in mg / dl ) , serum phosphorus ( in mg / dl ) , calciumphosphorus product ( Ca X PO4 ) , serum albumin ( in g / dl ) ,serum aluminium ( in ng / ml ) , serum alkaline phosphatase ( in U / L ) , and Intact serum Parathyroid hormone ( in pg / dl ) . All parameters were performed according to conventional methods used in Benha University Hospital Clinical Pathology Department .
All previous parameters were measured at the start of the study before administrating vitamin D3 to the studied patients .All patients have received a dose of 1000 IU per day of Vitamin D3 for 3 consecutive months, after which the same previously mentioned parameters were measured again at the end of these 3 months .
The study was done after approval of ethical board of Ain Shams university and an informed written consent was taken from each participant in the study. . Spearman correlation coefficients were used to assess the significant relation between two quantitative parameters in the same group (9) . Logistic regression analysis was used to assess the predictors of vitamin D3 effects on bone profile parameters .
STATISTICAL ANALYSIS
Chi -square test was used to compare two groups having qualitative data .Fischer Exact test was used also to compare two groups having low number of qualitative data . P value < 0.05 is considered to be significant , P = 0.051 -0.070 is considered to be borderline significant , P > 0.070 is considered nonsignificant.
RESULTS
In the present study , gender distribution has shown a borderline significant difference among non diabetic group I ( formed nearly equal male and female participants ) as compared to diabetic group 2 ( having a male gender predominance of 90.9 % ) . Within non diabetic group I ,after vitamin D3 use : there was a statistically significant rise in the mean values of RBCs count , serum creatinine , and protein creatinine ratio . Also , we found a statistically significant decrease in the mean values of intact PTH , e GFR , and serum Na . Multivariate logistic regression analysis performed for ESR 2 mean values , before vitamin D3 therapy , has shown that diabetic group had as much as 1.140 times chance of having higher level of ESR 2 than non diabetic group.
--------------------------------------------------------------------------------------------------

Table (5): Comparison of parameters levels within diabetic group II before and after vitamin D3 treatment -----------------------------------------------------------------------------------------------------------------------------------------
Multivariate logistic regression analysis performed for ESR2 mean values , after vitamin D3 therapy , has shown that diabetic group had as much as 1.048 times chance of having higher level of ESR2 than non diabetic group . After vitamin D3 use , within non diabetic group :Intact PTH had a statistically significant positive correlation to ESR2 , and a borderline significant positive correlation to ESR1 . Before vitamin D3 use , within diabetic group : monocytes % has shown a statistically significant positive correlation to serum calcium , and a statistically significant inverse correlation to serum phosphorus and intact PTH .
After vitamin D3 therapy , within diabetic group : ESR1 has shown a statistically significant inverse correlation to serum calcium and serum phosphorus , and a statistically significant positive correlation to intact PTH .ESR2 has shown a statistically significant inverse correlation to serum calcium . . At the start of the study before the use of vitamin D3 , serum calcium was found to be within target range for stage 3 chronic kidney disease within the 2 studied groups . Serum calcium level rise within diabetic group after vitamin D3 use, did not occur within the nondiabetic group after therapy . This could imply that diabetic group was more responsive to vitamin D3 effect . Respero and Arango (11) have reported a positive significant relationship between vitamin D and serum calcium ( P< 0.05 ) , within CKD patients stages 3 -5 .Adamasco et al.
DISCUSSION
(12) indicated that there was no change within serum calcium level after vitamin D3 use .
In our study , serum calcium and monocytes % recorded positive relationship within the diabetic group before vitamin D3 use ,but this relationship did not exist after treatment with vitamin D3 ,and this is could reflect vitamin D3 effect as a suppressor of inflammatory processes initiated via antigen -presenting cells activation , within an internal environment on its way to be a uremic milieu .
Lemiereet al.
( 13) have reported that the immunosuppressive effect of 1,25(OH)2D3 is correlated with a decrease in inflammatory cytokines such as IL -2 .
Serum phosphorus levels were within normal range within the 2 studied groups .Also serum phosphorus levels were not affected by vitamin D3 use within stage 3 CKD .
Respero and Arango (11) have reported an inverse significant relationship between vitamin D level and serum phosphorus , within CKD patients stages 3 -5 . Adamasco et al.
(12) found that there was no change within serum phosphorus level after vitamin D3 administration , and this deduction is in agreement with our results .
The inverse relationship between mean serum phosphorus and each of systolic blood pressure and eosinophils % , within non diabetic group before vitamin D3 use , could be explained as a link existing between phosphate as a uremic toxin and cardiac performance as represented by systolic blood pressure .Also this uremic toxin could at least partially explain hypo-immune responses to agents initiating allergic or hypersensitivity reactions . Both relationships have disappeared after vitamin D3 use within the nondiabetic patients .
The inverse relation between serum phosphorus and monocytes % within diabetic group before vitamin D3 use , has shown an antigenpresenting cell offending action of serum phosphorus in chronic kidney disease .This relationship did not exist after the use of vitamin D3 , which implies the improvement of immune response to foreign antigens after its administration .
Calcium -phosphorus product ( Ca X PO4 ) was very close to accepted level within the nondiabetic and the diabetic patients . Calciumphosphorus product was not affected by vitamin D3 use within the 2 studied groups . Respero and Arango (11) have reported an inverse significant relationship between vitamin D level and Calcium -phosphorus product .
After the use of vitamin D3 , intact parathyroid hormone levels showed a significant decrease from above normal level to around normal level , within the 2 studied groups . The diabetic state in diabetic group II did not have any impact on intact PTH level before therapy and also after vitamin D3 use .Adamasco et al. (12) in their study showed mild decrease in PTH levels after vitamin D use in chronic kidney disease .Respero and Arango (11) recorded an inverse relationship between vitamin D and intact PTH .
The positive relationship between Intact parathyroid hormone and patients age mean value , within non diabetic group I before vitamin D3 use , was confirmed by the findings of a study conducted by Khosla et al . (14) . The steroid vitamin D3 has abolished this relationship , which did not exist after the treatment with vitamin D3 in non diabetic group I patients . The inverse relationship between Intact PTH and monocytes % in diabetic group II before treatment , has disappeared after vitamin D3 use , which could be due to normalization of the mildly elevated i PTH after the treatment with vitamin D3.
Serum alkaline-phosphatase was within normal limit in the non-diabetic and the diabetic groups before vitamin D3 use and it was not affected by vitamin D3 therapy . This could imply that our patients were on the low bone turnover side . Against our findings , Respero and Arango (11) found an inverse significant relationship between vitamin D level and serum alkaline phosphatase .
ESR1 and ESR2 have shown higher values in the diabetic group , before and after use of vitamin D3 . This was confirmed by finding that ESR 2 had a chance of being higher within the diabetic group than non-diabetic group , before vitamin D3 use . This reflected the super-added inflammatory effect of diabetic state existence upon the chronic renal disease inflammatory state .Also , this result was supported by a significant O.R. ( 1.048 ) for diabetic group who had higher ESR2 than non-diabetic group after vitamin D3 use . O.R. value in itself has decreased after vitamin D3 use , but still the diabetic group had a higher chance of having higher ESR values than those of the non diabetic group . Our results are comparable to those found by Amina et al.
(15) who found higher ESR values within type 2 diabetic patients .
Within diabetic group II after vitamin D3 use , the inverse relationship between serum calcium level and each of ESR 1 and and ESR 2 , reflected the direct inflammation suppressing effect of calcium and indirectly the inflammation inhibitory effect of vitamin D3 through increasing serum calcium levels and other pathways . Al -Homrany (17) stated that one of the important factors contributing to high ESR level in uremia was hypo-calcemia, but this was not the case in our study .In the diabetic group after treatment , the positive relationship of ESR 1 to each of serum phosphorus mean level and intact I PTH , has reflected the role played by each of serum phosphorus and intact PTH as toxins existing within the imbalanced uremic milieu .
Almqvist et al.
(16) have found that , for patients having a state of hyper -parathyroidism for 1 year , it was enough to induce a rise in ESR .
Serum creatinine level rise in the diabetic and the non -diabetic groups , has occurred inspite of having a blood pressure figures around accepted values in both studied groups .Diabetic state did not play a role in making kidney function test worse within the diabetic group , whether before or after therapy .Our results are in agreement with those found by Adamasco et al.
(12) who stated an increase in kidney function tests following vitamin D use .
Estimated glomerular filtration rate ( e GFR ) rise after vitamin D3 therapy within the 2 studied groups , which implied that vitamin D3 has lessened the filtration pressure and pressure gradient between afferent and efferent arterioles , may be through affecting blood flow autoregulation within glomeruli by modulating renin -angiotensin system , which is necessary for maintaining filtration function within chronic kidney disease states . This assumption needs further studies at molecular mechanism level .Diabetic state did not affect the response of eGFR to vitamin D3 therapy in diabetic patients . Our findings were confirmed by those found by Adamasco et al. (12) . Protein / creatinine ratio has deteriorated within the 2 studied groups upon vitamin D3 use , being worse within the diabetic group .Against our results , Yu -Hsien Lai and Te -Chao Fang (19) stated that in the kidney , vitamin D exerts protective effects by inhibiting renal fibrosis , inflammation , and progression of proteinuria . Also , in controverse to our findings , Respero and Arango (11) have shown an inverse significant relationship between vitamin D level and 24 hour urinary protein .
Serum Na level decreased in non-diabetic group after vitamin D3 use , but not in the diabetic group . These findings confirmed the inhibitory effect of vitamin D3 on reninangiotensin system , which is hyper-stimulated by the existence of diabetic state together with the chronic renal disease state in diabetic group . Li (18) has reported that active vitamin D have shown a negative feedback on the reninangiotensin system .
CONCLUSION
Bone profile parameters have shown a positive response to vitamin D3 use in stage 3 CKD , except for serum phosphorus, calciumphosphorus product , and serum alkaline phosphatase levels .The response to vitamin D3 was more prominent in the diabetic group . Kidney function measurements and proteinuria have deteriorated within both groups upon vitamin D3 use , being worse in the diabetic group .Nutritional supplements of vitamin D3 is necessary to be considered in the formulation of the dietary regimen of the stage 3 CkD , in addition to other measures limiting the increase in serum phosphorus and calcium -phosphorus product levels . 
